24.06.2024 13:15:52 - dpa-AFX: *BIONTECH, DUALITYBIO RECEIVE FDA FAST TRACK DESIGNATION FOR BNT324/DB-1311 IN PROSTATE CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
BIONTECH SE SPON. ADRS 1 A2PSR2 Xetra 74,200 13.08.24 16:08:31 +0,400 +0,54% 74,200 74,350 74,150 73,800

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH